Amir Hossein Kashi[Author] - Search Results

Year	Number of Results
2009	1
2010	5
2011	1
2015	1
2016	4
2017	2
2018	2
2020	6
2021	4
2022	5
2023	6
2024	2

1

Kashi AH. Kashi AH. Urol J. 2020 May 16;17(3):327. doi: 10.22037/uj.v0i0.6064. Urol J. 2020. PMID: 32207541 Free article. No abstract available.

2

New Molecular Markers for Prostate Cancer Diagnosis.

Amiri M, Asadi Samani L, Kashi AH, Khadem N, Ziaee SAM, Mowla SJ. Amiri M, et al. Among authors: kashi ah. Urol J. 2024 Feb 28;21(1):1-13. doi: 10.22037/uj.v20i.7687. Urol J. 2024. PMID: 37818554 Free article. Review.

3

Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer.

Taheri M, Badrlou E, Hussen BM, Kashi AH, Ghafouri-Fard S, Baniahmad A. Taheri M, et al. Among authors: kashi ah. Front Oncol. 2023 Mar 21;13:1123101. doi: 10.3389/fonc.2023.1123101. eCollection 2023. Front Oncol. 2023. PMID: 37025585 Free PMC article. Review.

4

Circular RNAs in renal cell carcinoma: Functions in tumorigenesis and diagnostic and prognostic potentials.

Sayad A, Najafi S, Kashi AH, Hosseini SJ, Akrami SM, Taheri M, Ghafouri-Fard S. Sayad A, et al. Among authors: kashi ah. Pathol Res Pract. 2022 Jan;229:153720. doi: 10.1016/j.prp.2021.153720. Epub 2021 Nov 28. Pathol Res Pract. 2022. PMID: 34942510 Review.

5

RE: The tolerability of Potassium Citrate Tablet in patients with intolerance to Potassium Citrate Powder form.

Kashi AH. Kashi AH. Urol J. 2018 May 3;15(3):143-144. doi: 10.22037/uj.v15i3.4553. Urol J. 2018. PMID: 29790146 Free article. No abstract available.

6

COVID-19 and Semen: An Unanswered Area of Research.

Kashi AH. Kashi AH. Urol J. 2020 May 16;17(3):328. doi: 10.22037/uj.v0i0.6160. Urol J. 2020. PMID: 32333379 Free article. No abstract available.

7

National Lifetime Prevalence and Demographic Factors of Urolithiasis in Iran.

Basiri A, Kashi AH, Salehi Omran H, Borumandnia N, Golshan S, Narouie B, Hajebrahimi S, Mombeini H. Basiri A, et al. Among authors: kashi ah. Urol J. 2023 Feb 27;20(2):102-108. doi: 10.22037/uj.v20i.7576. Urol J. 2023. PMID: 36744405 Free article.

8

Which Medical Specialties or Subspecialties are at a Higher Risk of COVID-19 Infection or Mortality?

Kashi AH. Kashi AH. Urol J. 2021 Dec 4;19(2):159. doi: 10.22037/uj.v18i.7097. Urol J. 2021. PMID: 34862592 Free article. No abstract available.

9

Ultrasound-guided percutaneous nephrolithotomy in patients with retrorenal colon: a single-center experience.

Kashi AH, Nouralizadeh A, Sotoudeh M, Hamidi Madani M, Narouie B, Dadpour M, Najafi D, Ghasemi-Rad M. Kashi AH, et al. World J Urol. 2023 Jan;41(1):211-219. doi: 10.1007/s00345-022-04192-z. Epub 2022 Oct 28. World J Urol. 2023. PMID: 36305915

10

Comparing the outcomes of papillary and non-papillary access in percutaneous nephrolithotomy.

Kashi AH, Basiri A, Voshtasbi A, Ghead MA, Dadpour M, Nazempour F, Najafi D, Sotoudeh M, Narouie B. Kashi AH, et al. World J Urol. 2023 Feb;41(2):537-542. doi: 10.1007/s00345-022-04256-0. Epub 2022 Dec 17. World J Urol. 2023. PMID: 36527469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

35 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year